SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TechCreate Group Ltd. - Ordinary Shares - Class A

TechCreate Group Ltd. (TCGL) is experiencing an explosive, multi-thousand percent surge, triggering a massive short squeeze and sparking widespread community discussion as retail traders celebrate immense gains while others warn of a volatile pump reminiscent of past low-float "Singapore" or "Chinese" plays.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple Inc. is trending after delivering record-breaking Q1 earnings, driven by "unprecedented demand" for iPhones and strong China sales. Despite the blowout report, community debate rages over the stock's muted reaction, with many calling it "manipulated" or "priced in" amidst broader discussions on future growth and memory costs.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk Corp is currently trending due to its reported blowout earnings and blockbuster guidance, driven by insatiable demand for memory and storage products within the booming AI data center market. This has ignited intense community debate, with many predicting explosive future growth and a potential "supercycle" for the memory sector, while others caution about extreme overvaluation and a possible market bubble.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi Technologies is trending with high anticipation and anxiety ahead of its earnings report, where the community is debating whether strong results and guidance can overcome recent dilution concerns and drive a rebound in the stock.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as major financial outlets report that SpaceX is considering a potential merger with either Tesla or xAI, sparking intense debate among investors. Bulls anticipate significant synergy across Elon Musk's empire in AI, robotics, and space, while skeptics view the talks as a valuation pump or a move that could dilute existing shareholders.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata is trending after announcing a strategic partnership with Palantir Technologies and securing a contract with the U.S. Missile Defense Agency's SHIELD program. The community is buzzing about these collaborations, viewing them as a crucial entry into high-value government and sovereign AI markets, sparking optimism for a potential short squeeze amidst recent accumulation.

Virtuix Holdings, Inc.is a technology and entertainment company. It focuses on developing virtual reality (VR) hardware and software. The company was founded by Jan Goetgeluk on December 20, 2013 and is headquartered in Austin, TX.

Virtuix Holdings Inc. - Ordinary Shares - Class A

Virtuix Holdings (VTIX), a direct listed company, is generating significant market buzz due to extreme volatility and strong community speculation around a potential short squeeze, fueled by its low float and comparisons to other recent high-flyers. The innovative VR firm, supported by 138% year-over-year revenue growth and investor Mark Cuban, sees traders actively debating its valuation amidst its wild price swings.

Adlai Nortye Ltd. is a clinical-stage biopharmaceutical company, which engages in the provision of development of cancer therapies for patients with stages of tumors. It offers AN0025, a clinical stage, potential EP4 antagonist designed to modulate tumor microenvironment. The company was founded on May 9, 2018, and is headquartered in Hangzhou, China.

Adlai Nortye Ltd. - ADR

Adlai Nortye Ltd. American

Adlai Nortye Ltd. (ANL) is buzzing after announcing an exclusive licensing agreement for its pan-RAS inhibitor AN9025, a deal potentially worth up to $230 million with an upfront payment. This news has ignited significant after-hours trading and bullish price targets, as the community actively speculates on ANL's potential for a multi-day run, drawing comparisons to other volatile Chinese small-cap biotech plays.

KLA Corp. engages in the supply of process control and yield management solutions for the semiconductor and related nano-electronics industries. The company operates through the following segments: Semiconductor Process Control, Specialty Semiconductor Process, and PCB, Display and Component Inspection. The Semiconductor Process Control segment provides a comprehensive portfolio of inspection, metrology and data analytics products and related services. The Specialty Semiconductor Process segment develops and sells advanced vacuum deposition and etching process tools. The PCB, Display and Component Inspection segment enables electronic device manufacturers to inspect, test and measure PCBs, flat panel displays and ICs to verify their quality. Its products include manufactured chips, reticle, packaging, surface profilers, nanochemical testers, KT pro equipment, and compound semiconductors. The company was founded on July 9, 1975 and is headquartered in Milpitas, CA.

KLA Corp.

KLA Corp. is trending amid a wave of analyst upgrades and raised price targets, even as community sentiment reflects surprise over mixed stock reactions to recent earnings that generally beat estimates. The company is broadly recognized as a key enabler of the AI infrastructure boom through its essential process control solutions and advanced packaging growth.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Intensifying speculation regarding an improved acquisition offer from Sanofi, reportedly after a rejected $16/share bid, is driving conversation around Ocular Therapeutix. The community is highly optimistic about upcoming Phase 3 data for AXPAXLI in wet AMD and the recent hire of a former Eylea architect as CCO, fueling expectations for a substantial premium or strong independent commercialization.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Arch Therapeutics, Inc. is a development stage biotechnology company, which engages in the development and provision of hemostasis and sealant technology platform. Its product candidates include AC5 Devices, which designed to achieve hemostasis during surgical, wound, and interventional care. The company was founded by Rutledge Ellis-Behnke and Terrence W. Norchi on September 16, 2009 and is headquartered in Framingham, MA.

ARTH
Arch Therapeutics Inc

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest ARTH News

ARTHArch Therapeutics Inc